Showing results (31-40 of 101) with videos related to
Sort By:
Pageof 11
Translational Psychiatry|August 22, 2025
Cannabinoid 1 receptor availability in posttraumatic stress disorder: A positron emission tomography studyNachshon Korem, Anahita Bassir Nia, Ansel T Hillmer, et al.Synapse (New York, N.Y.)|April 24, 2020
Inverse changes in raphe and cortical 5-HT1B receptor availability after acute tryptophan depletion in healthy human subjectsStephen R Baldassarri, Eunkyung Park, Sjoerd J Finnema, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 8, 2013
Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporterMika Naganawa, Nabeel Nabulsi, Beata Planeta, et al.Molecular Psychiatry|September 25, 2020
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorderDeepak Cyril D'Souza, Rajiv Radhakrishnan, Mika Naganawa, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 4, 2014
Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humansMika Naganawa, Ming-Qiang Zheng, Nabeel Nabulsi, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 26, 2017
The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [11C]FLB457 PET StudyChristine M Sandiego, David Matuskey, Meaghan Lavery, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 23, 2016
First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430Mika Naganawa, Rikki N Waterhouse, Nabeel Nabulsi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Novel 18F-Labeled κ-Opioid Receptor Antagonist as PET Radiotracer: Synthesis and In Vivo Evaluation of 18F-LY2459989 in Nonhuman PrimatesSongye Li, Zhengxin Cai, Ming-Qiang Zheng, et al.Psychiatry Research. Neuroimaging|November 25, 2019
In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PETRajiv Radhakrishnan, David Matuskey, Nabeel Nabulsi, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 4, 2019
Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokersYasmin Zakiniaeiz, Ansel T Hillmer, David Matuskey, et al.Pageof 11